DHA Opposes SB 15 – Lyme Disease

Frame-Shape

DHA sent a letter to Senator Lopez on April 16th raising concerns with Senate Bill 15 to require the health care provider drawing blood for a Lyme disease laboratory test to provide written language that the results may be problematic and present a false negative or false positive result. DHA is concered this interferes with the patient/practitioner relationship and opposes legislating specific language regarding diseases and testing as new technologies and medical discoveries happen much faster than any legislative process.

Click here to read the letter.

Related Links

divider-shape

Comments – Request for Information: 340B Rebate Model Pilot Program, HHS Docket No. HRSA-2026-03042

Comments on Hospital Discharge Plans for Pregnant Patients (SB 301)

No results found.